This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07719/identifier/pdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07719/identifier/pubchem-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07719/identifier/pubchem-substance/
n6http://bio2rdf.org/drugbank:
n14http://linked.opendata.cz/resource/drugbank/drug/DB07719/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07719/identifier/chemspider/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07719
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07719 n7:DB07719
dcterms:title
3(R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER
adms:identifier
n10:99444190 n11:ENT n12:5327155 n13:4484397 n14:DB07719
n3:IUPAC-Name
n4:271B5FBE-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5FC4-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5FC3-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5FC0-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5FC1-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5FC2-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5FBC-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5FBD-363D-11E5-9242-09173F13E4C5 n4:271B5FBA-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5FBB-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5FCA-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5FCB-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5FC5-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5FC6-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5FC8-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5FC7-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5FC9-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5FD0-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5FD2-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5FD3-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5FCF-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5FCE-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5FD1-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5FBF-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5FCC-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5FCD-363D-11E5-9242-09173F13E4C5